Safety Advisory Notice - Classification of MPXV Diagnostic Samples and Waste
The U.S. Department of Transportation’s Pipeline and Hazardous Materials Safety Administration (PHMSA) is sharing new advice from the Centers for Disease Control and Prevention (CDC) regarding diagnostic samples and clinical waste containing Monkeypox virus (MPXV) in Clade I or II. The advice clarifies that samples and clinical waste should be designated as Category B infectious substances except when they contain or are contaminated with cultures of Clade I MPXV.
Read the Full Article

CDC Updates and Simplifies Respiratory Virus Updates
CDC released updated recommendations for how people can protect themselves and their communities from respiratory viruses, including COVID-19. The new guidance brings a unified approach to addressing risks from a range of common respiratory viral illnesses, such as COVID-19, flu, and RSV, which can cause significant health impacts and strain on hospitals and health care workers. CDC is making updates to the recommendations now because the United States is seeing far fewer hospitalizations and deaths associated with COVID-19 and because we have more tools than ever to combat flu, COVID-19, and RSV. As part of the guidance, CDC provides active recommendations on core prevention steps and strategies and additional considerations for people who are at higher risk of severe illness from respiratory viruses, including older adults, young children, people with compromised immune systems, people with disabilities, and pregnant people.
Learn more at CDC.gov